Myomo (MYO) Capital Expenditures Growth (3y) (2020 - 2025)
Powered by 
Analysis
Myomo (MYO) Capital Expenditures Growth (3y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -0.66% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -14.20% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 12.42% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 9.94% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 10.89% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 6.38% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 12.81% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 9.52% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 597.33% |
| Jun 30, 2025 | 90.53% |
| Mar 31, 2025 | 137.79% |
| Dec 31, 2024 | 230.01% |
| Sep 30, 2024 | 80.12% |
| Jun 30, 2024 | -16.24% |
| Mar 31, 2024 | 10.37% |
| Dec 31, 2023 | 27.00% |
| Sep 30, 2023 | 34.13% |
| Mar 31, 2023 | 78.87% |
| Dec 31, 2022 | -37.30% |
| Sep 30, 2022 | 19.54% |
| Jun 30, 2022 | 21.41% |
| Mar 31, 2022 | 109.77% |
| Dec 31, 2021 | 36.09% |
| Sep 30, 2021 | 15.18% |
| Jun 30, 2021 | 130.76% |
| Mar 31, 2021 | -11.84% |
| Dec 31, 2020 | -36.28% |
| Sep 30, 2020 | 114.95% |